Phosphodiesterase Type-4 inhibitors
Drug Safety Update
January 2017: Apremilast (Otezla ▼): risk of suicidal thoughts and behaviour
NICE Guidance (See also drug specific guidance below)
NG100: Rheumatoid arthritis in adults: management, July 2018 (updated October 2020)
Blue-teq funding form to be completed
| Pack | Price |
|---|---|
| 4 tablet |
| Pack | Price |
|---|---|
| 4 tablet |
| Pack | Price |
|---|---|
| 19 tablet | |
| 56 tablet (4 x 14 tablets) | £550.00 |